BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15694205)

  • 21. Myelination of a fetus with Pelizaeus-Merzbacher disease: immunopathological study.
    Shiraishi K; Itoh M; Sano K; Takashima S; Kubota T
    Ann Neurol; 2003 Aug; 54(2):259-62. PubMed ID: 12891682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pathways of oligodendrocyte apoptosis revealed by mutations in the proteolipid protein gene.
    Southwood C; Gow A
    Microsc Res Tech; 2001 Mar; 52(6):700-8. PubMed ID: 11276122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pelizaeus-Merzbacher disease(PMD)/spastic paraplegia 2(SPG2)].
    Eto Y
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):536-7. PubMed ID: 11032015
    [No Abstract]   [Full Text] [Related]  

  • 24. Aberrant trafficking of a proteolipid protein in a mild Pelizaeus-Merzbacher disease.
    Koizume S; Takizawa S; Fujita K; Aida N; Yamashita S; Miyagi Y; Osaka H
    Neuroscience; 2006 Sep; 141(4):1861-9. PubMed ID: 16844304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal diagnosis of Pelizaeus-Merzbacher disease.
    Garbern J; Hobson G
    Prenat Diagn; 2002 Nov; 22(11):1033-5. PubMed ID: 12424770
    [No Abstract]   [Full Text] [Related]  

  • 26. Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease.
    Gruenenfelder FI; Thomson G; Penderis J; Edgar JM
    J Anat; 2011 Jul; 219(1):33-43. PubMed ID: 21401588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
    Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
    Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraventricular transplantation of oligodendrocyte progenitors into a fetal myelin mutant results in widespread formation of myelin.
    Learish RD; Brüstle O; Zhang SC; Duncan ID
    Ann Neurol; 1999 Nov; 46(5):716-22. PubMed ID: 10553988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic background influences UPR but not PLP processing in the rumpshaker model of PMD/SPG2.
    McLaughlin M; Karim SA; Montague P; Barrie JA; Kirkham D; Griffiths IR; Edgar JM
    Neurochem Res; 2007 Feb; 32(2):167-76. PubMed ID: 16944321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple splice isoforms of proteolipid M6B in neurons and oligodendrocytes.
    Werner H; Dimou L; Klugmann M; Pfeiffer S; Nave KA
    Mol Cell Neurosci; 2001 Dec; 18(6):593-605. PubMed ID: 11749036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelizaeus-Merzbacher disease-associated proteolipid protein 1 inhibits oligodendrocyte precursor cell differentiation via extracellular-signal regulated kinase signaling.
    Miyamoto Y; Torii T; Tanoue A; Yamauchi J
    Biochem Biophys Res Commun; 2012 Jul; 424(2):262-8. PubMed ID: 22750001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic background determines phenotypic severity of the Plp rumpshaker mutation.
    Al-Saktawi K; McLaughlin M; Klugmann M; Schneider A; Barrie JA; McCulloch MC; Montague P; Kirkham D; Nave KA; Griffiths IR
    J Neurosci Res; 2003 Apr; 72(1):12-24. PubMed ID: 12645075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-acetylaspartylglutamate (NAAG) in Pelizaeus-Merzbacher disease.
    Burlina AP; Ferrari V; Burlina AB; Ermani M; Boespflug-Tanguy O; Bertini E;
    Adv Exp Med Biol; 2006; 576():353-9; discussion 361-3. PubMed ID: 16802726
    [No Abstract]   [Full Text] [Related]  

  • 34. Compensating for central nervous system dysmyelination: females with a proteolipid protein gene duplication and sustained clinical improvement.
    Inoue K; Tanaka H; Scaglia F; Araki A; Shaffer LG; Lupski JR
    Ann Neurol; 2001 Dec; 50(6):747-54. PubMed ID: 11761472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare Case of Female with Pelizaeus Mertzbacher Disease due to deletion of Proteolipid Protein 1: A Case Report.
    Kinoshita M; Roston W
    JNMA J Nepal Med Assoc; 2018; 56(214):967-969. PubMed ID: 31065145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease.
    Wolf NI; Sistermans EA; Cundall M; Hobson GM; Davis-Williams AP; Palmer R; Stubbs P; Davies S; Endziniene M; Wu Y; Chong WK; Malcolm S; Surtees R; Garbern JY; Woodward KJ
    Brain; 2005 Apr; 128(Pt 4):743-51. PubMed ID: 15689360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for possible interactions between PLP and DM20 within the myelin sheath.
    McLaughlin M; Hunter DJ; Thomson CE; Yool D; Kirkham D; Freer AA; Griffiths IR
    Glia; 2002 Jul; 39(1):31-6. PubMed ID: 12112373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteolipid protein gene mutation induces altered ventilatory response to hypoxia in the myelin-deficient rat.
    Miller MJ; Haxhiu MA; Georgiadis P; Gudz TI; Kangas CD; Macklin WB
    J Neurosci; 2003 Mar; 23(6):2265-73. PubMed ID: 12657685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel PLP1 deletion causing classic Pelizaeus-Merzbacher disease.
    Prior C; Muñoz-Calero M; Gómez-Gonzalez C; Martinez-Montero P; Barrio L; Poo P; Martorell L; Molano J
    J Neurol Sci; 2019 Feb; 397():135-137. PubMed ID: 30616056
    [No Abstract]   [Full Text] [Related]  

  • 40. Patient-derived iPS cells for unveiling the molecular pathology of Pelizaeus-Merzbacher disease: a commentary on 'Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication'.
    Inoue K
    J Hum Genet; 2012 Sep; 57(9):553-4. PubMed ID: 22786577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.